No Detail Found!

Emerging Therapeutic Targets: Rheumatoid Arthritis.

Author(s)
Umme Habiba Hasan Department of Pharmacology, College of Pharmacy, University of Sargodha, Sargodha, Pakistan
Ambreen Malik Uttra Department of Pharmacology, College of Pharmacy, University of Sargodha, Sargodha, Pakistan
Mehreen Malik Uttra District Head Quarter (DHQ) Teaching Hospital Sargodha, Sargodha, Pakistan
Malik Ghulam Muhammad Uttra Department of Community Medicine, Sargodha Medical College, Sargodha, Pakistan
Abstract
Rheumatoid arthritis involves a range of various intricate pathophysiologic facets that contribute to synovitis, synovial hyperplasia, autoantibodies generation as well as cartilage and bone damage leading to functional impairment. Although current therapeutic modalities including NSAIDs, corticosteroids, DMARDs and biologic response modifiers target various contributory factors but still not effectual in the apt management of rheumatoid arthritis, thus pointing towards the investigation of new prospects to not only manage but cure this perplexing disorder. Hence, Tumor necrosis factor-a converting enzyme (TACE/ADAM17), Toll like receptor 5 (TLR5), Citrullinated immunoglobulin binding protein (citBiP), anti-BRAF autoantibodies, Perforin and membrane attack complex (MAC), Migration inhibitory factor of macrophages (MIF), Mucin (MUCs), IL-1ß, NLRP3 inflammasome signaling, NETosis, Hepatocyte growth factor (HGF), progranulin, PTPN22, iRHOM2, immune mediated immunolytic pathways, tenascin-C and various chemokines are intriguing areas, which in future might be more beneficial in the treatment and management of arthritis in majority of populace with minimum risks.
Publication Details
Page(s) 208-215
DOI DOI not available
Published Journal: RADS Journal of Pharmacy & Pharmaceutical Sciences, Volume: 6, Issue: 3, Year: 2018

Request the full text from PASTIC

Keywords
innovative targets, therapeutics
References
KimW,ParkS,ChoiC,KimYR,ParkI,SeoC, 2016.Evaluation of anti-inflammatory potential of the new Ganghwaljetongyeum on adjuvant-induced inflammatory arthritis in rats,Evid Based Complement Alternat Med 1230294 -
ZhengC-J,ZhaoX-X,Ai H-W , Lin B,HanT,JiangY-P, 2014.Therapeutic effects of standardized Vitex negundo seeds extract on complete Freund's adjuvant induced arthritis in rats,Phytomed 21 838 -46
SukketsiriW,ChonpathompikunlertP,TanasawetS,ChoosriN,WongtawatchaiT., 2016.Effects of Apium graveolens extract on the oxidative stress in the liver of adjuvant-induced arthritic rats,Prev Nutr Food Sci 21 79 -84
WeiZF,JiaoXL,WangT,LuQ,XiaYF,WangZT, 2013.Norisoboldine alleviates joint destruction in rats with adjuvant-induced arthritis by reducing RANKL, IL-6, PGE2, and MMP-13 expression,Acta Pharmacol Sin 34 403 -13
AdeneyeAA,OreagbaAI,IsholaIO,KalejaiyeHA, 2014.Evaluation of the anti-arthritic activity of the hydroethanolic leaf extract of Alchornea cordifolia in rats,Afr J Tradit Complement Altern Med 11 402 -10
Rong-junHE,Zhi-hongYU,ZhangR, 2014.Protein tyrosine phosphatases as potential therapeutic targets,Acta Pharmacol Sin 35 1227 -46
SchellerJ,ChalarisA,GarbersC,Rose-John S, 2011.a molecular switch to control inflammation and tissue regeneration,Trends in Immunol 32 380 -7
Rose-JohnS., 2013.ADAM17 shedding, TACE as therapeutic targets,Pharmacol Res 71 19 -22
KimS,ChenZ,ChamberlainND,VolinMV,SwedlerW,VolkovS, 2013.Angiogenesis in rheumatoid arthritis is directly fostered by TLR5 ligation and indirectly through IL-17 induction,Arthritis Rheum 65 2024 -36
KimS,ChenZ,ChamberlainND,EssaniAB,VolinMV,AminMA, 2014.Ligation of TLR5 promotes myeloid cell infiltration and differentiation into mature osteoclasts in rheumatoid arthritis and experimental arthritis,J Immunol 193 3902 -13
HamaguchiM,KawahitoY,IshinoH,TakeuchiN,TokunagaD,HojoT, 2011.Mucin from rheumatoid arthritis synovial fluid enhances interleukin-6 production by human peripheral blood mononuclear cells,Human Immunol 72 241 -8
MorandEF,LeechM,BernhagenJ. MIF:, 2006.a new cytokine link between rheumatoid arthritis and atherosclerosis,Nat Rev Drug Discov 5 399 -410
KasamaT,OhtsukaK,SatoM,TakahashiR,WakabayashiK,KobayashiK., 2010.Macrophage migration inhibitory factor: A multifunctional cytokine in rheumatic diseases,Arthritis 106202 -
AugerI,CharpinC,BalandraudN,MartinM,RoudierJ, 2012.Autoantibodies to PAD4 and BRAF in rheumatoid arthritis,Autoimmun Rev 11 801 -3
ShodaH,FujioK,ShibuyaM,OkamuraT,SumitomoS,OkamotoA, 2011.Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis,Arthritis Res Ther 13 R191 -
KhandpurR,Carmona-RiveraC,VivekanandanGiriA,GizinskiA,YalavarthiS,KnightJS, 2013.NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis,Sci Transl Med 5 178ra40 -
RabquerBJ,KochAE., 2013.NK4 therapy: a new approach to target angiogenesis and inflammation in rheumatoid arthritis,Arthritis Res Ther 15 119 -
RomeroV,Fert-BoberJ,NigrovicPA,DarrahE,HaqueUJ,LeeDM, 2013.Immune-mediated poreforming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis,Sci Transl Med 5 209ra150 -
WalleLV,OpdenboschNV,JacquesP,FossoulA,VerheugenE,VogelP, 2014.Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis,Nature 512 69 -73
ChenS,SunB, 2013.Negative regulation of NLRP3 inflammasome signaling,Protein Cell 4 251 -8
SoA,BussoN., 2014.The concept of the inflammasome and its rheumatologic implications,Joint Bone Spine 81 398 -402
MidwoodK,SacreS,PiccininiAM,InglisJ,TrebaulA,ChanE, 2009.Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease,Nat Med 15 774 -81
RuhmannM,PiccininiAM,KongPL,MidwoodKS, 2012.Endogenous activation of adaptive immunity. Tenascin-C drives interleukin-17 synthesis in murine arthritic joint disease,Arthritis Rheum 64 2179 -90
ChenX,OppenheimJJ,HowardOMZ, 2004.Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): Inhibitory effects of traditional Chinese medicinal components,Cell Mol Immunol 1 336 -42
ShadidiKR, 2004.New drug targets in rheumatoid arthritis focus on chemokines,Biodrugs 18 181 -7
SzekaneczZ,PakozdiA,SzentpeteryA,BesenyeiT,KochAE, 2010.Chemokines and angiogenesis in rheumatoid arthritis,Front Biosci (Elite Ed) 1 44 -51
IssureePDA,MaretzkyT,McIlwainDR,MonetteS,QingX,LangPA, 2013.iRHOM2 is a critical pathogenic mediator of inflammatory arthritis,J Clin Invest 123 928 -32
LichtenthalerSF, 2013.iRHOM2 takes control of rheumatoid arthritis,J Clin Invest 123 560 -2
TangW,LuY,TianQY,ZhangY,GuoFJ,LiuGY, 2011.The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice,Science 332 478 -84
2011.Progranulin: A promising therapeutic target for rheumatoid arthritis,FEBS Lett 585 3675 -80
Diaz-GalloLM,MartinJ., 2012.PTPN22 splice forms: a new role in rheumatoid arthritis,Genome Med 4 13 -
BurnGL,SvenssonL,Sanchez-BlancoC,SainiM,CopeAP, 2011.Why is PTPN22 a good candidate susceptibility gene for autoimmune disease,FEBS Lett 585 3689 -98
0

Citations

0

Downloads

117

Views